Loading...
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration: The COMPLETE Study
PURPOSE: To evaluate the effect of eculizumab, a systemic inhibitor of complement component (C5), on the growth of geographic atrophy (GA) in patients with age-related macular degeneration (AMD). DESIGN: Prospective, double-masked, randomized clinical trial. PARTICIPANTS: Patients with GA measuring...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4015213/ https://ncbi.nlm.nih.gov/pubmed/24289920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2013.09.044 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|